ResearcherMoffitt Cancer CenterNo recent work listed
Manish R. Patel
Matched on ORCID iD 0000-0001-6836-2364; OpenAlex author ID A5005718112. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 4
- Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s10637-020-01000-6↗
- Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I … Co-author DOI 10.1634/theoncologist.2020-0474↗
- Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. Co-author DOI 10.1002/jso.21954↗
- Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer. Co-author PMID 22368736↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zev A. Wainberg · 2 shared papers, 2020–2021 · strength 0.19
- Paper Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcin… DOI 10.1007/s10637-020-01000-6↗
- Paper Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic… DOI 10.1634/theoncologist.2020-0474↗
- Johanna C. Bendell · 2 shared papers, 2020–2021 · strength 0.19
- Paper Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcin… DOI 10.1007/s10637-020-01000-6↗
- Paper Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic… DOI 10.1634/theoncologist.2020-0474↗
- Milind M. Javle · 1 shared paper, 2021 · strength 0.10
- Raid M. Aljumaily · 1 shared paper, 2021 · strength 0.10
- Todd Michael Bauer · 1 shared paper, 2021 · strength 0.10
- Joel Randolph Hecht · 1 shared paper, 2021 · strength 0.10
- Jeffrey R. Infante · 1 shared paper, 2021 · strength 0.10
- Shubham Pant · 1 shared paper, 2021 · strength 0.10
- Aung Naing · 1 shared paper, 2021 · strength 0.10
- Alexander Starodub · 1 shared paper, 2020 · strength 0.09
- Jordan D. Berlin · 1 shared paper, 2020 · strength 0.09
- Gregory M. Springett · 2 shared papers, 2011 · strength 0.05
- Sarah E. Hoffe · 2 shared papers, 2011 · strength 0.05
- Mokenge Peter Malafa · 2 shared papers, 2011 · strength 0.05
- Pamela Joy Hodul · 2 shared papers, 2011 · strength 0.05
- Michael David Chuong · 1 shared paper, 2011 · strength 0.03
- Ravi Shridhar · 1 shared paper, 2011 · strength 0.03
- Barbara Ann Centeno · 1 shared paper, 2011 · strength 0.03
- James F. Helm · 1 shared paper, 2011 · strength 0.03
- Jason B. Klapman · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.